APSIS HEALTHCARE
SIMPLIFYING DRUG DEVELOPMENT
OUR TECHNOLOGY
01 / PROCESS ANALYTICAL TECHNOLOGY
02 / SMART MANUFACTURING PLATFORM
03 / CONTINUED RESEARCH AND SUPPORT
Our innovation in PAT is spearheading a new generation of process analytics that brings the power of a QC Lab to the Manufacturing Floor. Our models are designed to be upwards compatible with existing Manufacturing Platforms.
Available as Custom-Built or Off-the-Shelf, we can outfit your facility with our Process Hardware that is at the focus of our research into Continuous Manufacturing. Whether you're in Development or at Commercial, we can fit your needs. We are offering custom automation development starting September 2019.
We are continuously growing our partnerships to enrich the PAT platforms that we are building. We plan to be a mainstay in the space of advanced biopharmaceutical and drug manufacturing, supporting our customers and investing in new technologies.
MEET APSIS HEALTHCARE
OUR JOURNEY
As a group of engineers and biochemists, we see the power of intersection between technology and biology. We are developing technology where we see gaps and connecting resources where we see inefficiencies. We are starting our journey in the Biotech CMC world and plan to deploy our resources across the healthcare system.
PRODUCT DEVELOPMENT
As a company, our goal is to bring down barriers within drug development. We are building a suite of hardware, software & a unique set of services that address challenges facing drug scientists, process engineers and decision makers. We are building a continuum of tools and services that aid teams taking drugs from research benches to clinics around the globe.
CUSTOM TAILORED
AUTOMATION
As our opening gambit in this space, we are producing future-ready automation by using rational design principles guided by our CMC experience. The right automation today can get you ready for Commercial Manufacturing without having to reinvest precious capital and simply plugging into our targeted product line.
THE
TEAM
We are drawing from the collective Process, Analytical and Regulatory experience of a dynamic team and a highly experienced group of strategic advisors.